Cutaneous leukocytoclastic vasculitis associated with letrozole-Reference-Cited by-同舟云学术

Cutaneous leukocytoclastic vasculitis associated with letrozole

Published:2013-05-14 Issue:2 Volume:20 Page:146-148
ISSN:1078-1552
Container-title:Journal of Oncology Pharmacy Practice
language:en
Short-container-title:J Oncol Pharm Pract

Author:

Digklia Antonia¹,Tzika Evangelia¹,Voutsadakis Ioannis A¹

Affiliation:

1. Centre Pluridisciplinaire d’Oncologie, Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland

Abstract

Aromatase inhibitors are increasingly used in the treatment of early and metastatic breast cancer. They can produce various skin adverse effects but are only rarely associated with cutaneous vasculitis. We report the first case of cutaneous vasculitis clearly associated with the use of aromatase inhibitor letrozole.

Publisher

SAGE Publications

Subject

Pharmacology (medical),Oncology

Link

http://journals.sagepub.com/doi/pdf/10.1177/1078155213480535

Reference9 articles.

1. Aromatase Inhibitor Versus Tamoxifen in Postmenopausal Woman With Advanced Breast Cancer: A Literature-Based Meta-Analysis

2. Erythema nodosum secondary to aromatase inhibitor use in breast cancer patients: case reports and review of the literature

3. Anastrozole-induced subacute cutaneous lupus erythematosus

4. Aromatase inhibitor-induced skin adverse reactions: exemestane-related cutaneous vasculitis

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Adherence to adjuvant hormonal therapy in localised breast cancer;European Journal of Cancer Care;2022-10-07

2. Drug-Induced Vasculitis;Drug Eruptions;2022

3. Delayed hypersensitivity reactions to multiple aromatase inhibitors followed by successful desensitization to letrozole;Annals of Allergy, Asthma & Immunology;2021-09

4. Dermatologic Adverse Effects of Anticancer Therapy IV: Endocrine, Biologic, Radiation and Other Therapies;Dermato-Oncology Study Guide;2021

5. Necrotizing leukocytoclastic small vessel vasculitis associated with letrozole: A case report;Int. Journal of Clinical Pharmacology and Therapeutics;2020-12-01